Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MYOM3 antisense RNA 1 (MYOM3-AS1) is a predicted antisense RNA gene found on the human genome, mapped antisense to the MYOM3 protein-coding gene. As a long non-coding RNA (lncRNA), MYOM3-AS1 may have regulatory functions over its sense counterpart, but there is no published evidence for its involvement in any biological process, therapeutic mechanism, or disease context. It is not currently considered a therapeutic target, nor are there aliases, drugs, mechanisms, or biomarkers associated with it. There are no indications of spelling errors or misidentification; the name and locus are consistent with current genomic annotations. Further research would be needed to clarify any functional or disease associations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MYOM3 antisense RNA 1 (MYOM3-AS1).